19 June 2013
Keywords: Novartis, Lucentis, Diabetic macular edema, DME, UK, NICE
Article | 05 October 2012
UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE), in new draft guidance issued this morning (October 5) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 October 2012
4 October 2012
18 June 2013
© 2013 thepharmaletter.com